2026 Boston Pharma Statistics Symposium - Day 2, Main Event

Tickets on this page are for the main event on November 13. Tickets for the in-person short courses on November 12 can be found on this page (in-person) or this page (virtual).

All participants must register by Friday, November 6, 12 pm EST. The registration fee covers a light breakfast, lunch, snacks, and symposium materials.

Please note: Valid photo ID is required at registration and must be presented to the Novo Nordisk security. Requirements to enter Novo buildings are subject to change.

Join us at the 2026 Boston Pharmaceutical Statistics Symposium on November 13, hosted by the Boston Chapter of the American Statistical Association (BCASA). The 2026 symposium theme is Bridging Innovation to Implementation: Statistics and AI in Drug Development. This annual event, held this year at Novo in Lexington, MA, offers a unique platform for sharing cutting-edge statistical applications and research in the biotech-pharma industry.

It's an ideal opportunity for industry statisticians, academics, students, and professionals interested in pharmaceutical statistical topics to connect and exchange insights within Greater Boston's thriving pharmaceutical community. The symposium features a full day of engaging activities, including thought-provoking invited talks, a dynamic poster session, and ample networking opportunities. Two short courses will be offered on November 12, one day before the symposium.

Don't miss enhancing your knowledge and expanding your professional network. Mark your calendar now and be part of this impactful event!

Keynote speakers

• Stuart Bailey, PhD – EMD Serono
• Justine Rochon, PhD – Takeda.
  Rethinking Clinical Development with AI: A Leadership Agenda for Statisticians

Invited speakers

• Wenting Wang, PhD – Sanofi.
  Reasoning Over Biomarker Networks: Turning Biological Connections into Actionable Clinical Insight
• Debbie M. Cheng, ScD – Boston University School of Public Health.
  Building AI Capacity in Public Health
• Sébastien Marque, PhD – HORIANA.
  The use of synthetic data to augment controlled clinical trials: A Bayesian network framework
• Anastasia Ivanova, PhD – University of North Carolina at Chapel Hill.
  The PrecISE Clinical Trial: Did We Make the Right Decisions?
• Shuguang Huang, PhD – Stat4ward.
  Statistics in CDx Development
• Krishna Pilambi, PhD – Pfizer.
  AI agents for Integrated Evidence Planning in biopharmaceutical R&D: From fragmented pre-work to a shared, traceable evidence foundation
• Bruno Scodari, PhD – Biogen.
  Enhancing Early Alzheimer’s Disease Clinical Trials Through Prognostic Score Covariate Adjustment

More information on the 2026 Boston Pharmaceutical Statistics Symposium can be found on our website.

Our Sponsors

We thank our colleagues at Novo for hosting this event. Financial support from our sponsors is gratefully acknowledged.

• Platinum sponsor: Sanofi, Insilicom, Cytel
• Gold sponsor: Takeda, Alnylam, Servier, PhaseV, Roche/Genentech, Stat4Ward
• Silver sponsor: Astellas and Metrum
• Poster sponsor: ASA Biopharmaceutical Section
• Short course sponsor: Pfizer